University of California Los Angeles - Jonsson Comprehensive Cancer Center — Los Angeles, California

University of California Los Angeles - Jonsson Comprehensive Cancer Center is a clinical research site located in Los Angeles, California, United States.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

University of California Los Angeles - Jonsson Comprehensive Cancer Center has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Melanoma, Non-small Cell Lung Cancer, Glioblastoma, Adult.

Sponsors: Millennium Pharmaceuticals, Inc., Genentech, Inc., Kazia Therapeutics Limited.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California Los Angeles - Jonsson Comprehensive Cancer Center?

University of California Los Angeles - Jonsson Comprehensive Cancer Center has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California Los Angeles - Jonsson Comprehensive Cancer Center conducted?

University of California Los Angeles - Jonsson Comprehensive Cancer Center has 3 clinical trials on record, with 1 currently active. Their work covers Melanoma, Non-small Cell Lung Cancer, Glioblastoma, Adult.

Is University of California Los Angeles - Jonsson Comprehensive Cancer Center accredited by Crixeo Health?

University of California Los Angeles - Jonsson Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California Los Angeles - Jonsson Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.